View Item 

Show simple item record

Serial assessment of the electrocardiographic strain pattern for prediction of new‐onset heart failure during antihypertensive treatment: the LIFE study

dc.contributor.authorOkin, Peter M.en_US
dc.contributor.authorOikarinen, Lasseen_US
dc.contributor.authorViitasalo, Mattien_US
dc.contributor.authorToivonen, Laurien_US
dc.contributor.authorKjeldsen, Sverre E.en_US
dc.contributor.authorNieminen, Markku S.en_US
dc.contributor.authorEdelman, Jonathan M.en_US
dc.contributor.authorDahlöf, Björnen_US
dc.contributor.authorDevereux, Richard B.en_US
dc.date.accessioned2014-03-05T18:19:13Z
dc.date.available2014-03-05T18:19:13Z
dc.date.issued2011-04en_US
dc.identifier.citationOkin, Peter M.; Oikarinen, Lasse; Viitasalo, Matti; Toivonen, Lauri; Kjeldsen, Sverre E.; Nieminen, Markku S.; Edelman, Jonathan M.; Dahlöf, Björn ; Devereux, Richard B. (2011). "Serial assessment of the electrocardiographic strain pattern for prediction of newâ onset heart failure during antihypertensive treatment: the LIFE study." European Journal of Heart Failure 13(4): 384-391. <http://hdl.handle.net/2027.42/106144>en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106144
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherHypertensionen_US
dc.subject.otherHypertrophyen_US
dc.subject.otherElectrocardiogramen_US
dc.titleSerial assessment of the electrocardiographic strain pattern for prediction of new‐onset heart failure during antihypertensive treatment: the LIFE studyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid21239405en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106144/1/ejhfhfq224.pdf
dc.identifier.doi10.1093/eurjhf/hfq224en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.identifier.citedreferenceDahlöf B Devereux RB Kjeldsen SE Julius S Beevers G de Faire U Fyhrquist F Ibsen H Kristiansson K Lederballe‐Pedersen O Lindholm LH Nieminen MS Omvik P Oparil S Wedel H for the LIFE study group Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 2002 359 995 1003en_US
dc.identifier.citedreferenceVerdecchia P Schillaci G Borgioni C Ciucci A Gattobigio R Zampi I Porcellati C Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy J Am Coll Cardiol 1998 31 383 390en_US
dc.identifier.citedreferenceOkin PM Devereux RB Nieminen MS Jern S Oikarinen L Viitasalo M Toivonen L Kjeldsen SE Julius S Snapinn S Dahlöf B Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients Hypertension 2004 44 48 54en_US
dc.identifier.citedreferenceHsieh BP Pham MX Froelicher VF Prognostic value of electrocardiographic criteria for left ventricular hypertrophy Am Heart J 2005 150 161 167en_US
dc.identifier.citedreferenceLevy D Salomon M D'Agostino RB Belanger AJ Kannel WB Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy Circulation 1994 90 1786 1793en_US
dc.identifier.citedreferenceVerdecchia P Reboldi G Angeli F Avanzini F de Simone G Pede S Perticone F Schillaci G Vanuzzo D Maggioni AP on behalf of the HEART Survey Study Group Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: The HEART Survey Study Am J Hypertens 2007 20 997 1004en_US
dc.identifier.citedreferenceVerdecchia P Sleight P Mancia G Fagard R Trimarco B Schmieder RE Kim J‐H Jennings G Jansky P Chen J‐H Liu L Gao P Probstfield J Teo K Yusuf S for the ONTARGET/TRANSCEND Investigators Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the ongoing telmisartan alone and in combination with ramipril global end point trial and the telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease Circulation 2009 120 1380 1389en_US
dc.identifier.citedreferenceOkin PM Devereux RB Nieminen MS Jern S Oikarinen L Viitasalo M Toivonen L Kjeldsen SE Dahlöf B for the LIFE Study Investigators Electrocardiographic strain pattern and prediction of new‐onset congestive heart failure in hypertensive patients: The LIFE Study Circulation 2006 113 67 73en_US
dc.identifier.citedreferenceMathew J Sleight P Lonn E Johnstone D Pogue J Yi Q Bosch J Sussex B Probstfield J Yusuf S Heart Outcomes Prevention Evaluation (HOPE) Investigators Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin‐converting enzyme inhibitor ramipril Circulation 2001 104 1615 1621en_US
dc.identifier.citedreferenceFagard RH Staessen JA Thijs L Celis H Birkenhager WH Bulpitt CJ de Leeuw PW Leonetti G Sarti C Tuomilehto J Webster J Yodfat Y Systolic Hypertension in Europe (Syst‐Eur) Trial Investigators Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension Hypertension 2004 44 459 464en_US
dc.identifier.citedreferenceOkin PM Devereux RB Jern S Kjeldsen SE Julius S Nieminen MS Snapinn S Harris KE Aurup P Edelman JM Wedel H Lindholm LH Dahlöf B Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events: The LIFE Study JAMA 2004 292 2343 2349en_US
dc.identifier.citedreferenceOkin PM Devereux RB Harris KE Jern S Kjeldsen SE Julius S Edelman JM Dahlöf B for the LIFE Study Investigators Reduction of electrocardiographic left ventricular hypertrophy is associated with decreased heart failure hospitalization in hypertensive patients Ann Intern Med 2007 147 311 319en_US
dc.identifier.citedreferenceOkin PM Oikarinen L Viitasalo M Toivonen L Kjeldsen SE Nieminen MS Edelman JM Dahlöf B Devereux RB Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the LIFE study Circulation 2009 119 1183 1891en_US
dc.identifier.citedreferenceOkin PM Devereux RB Harris KE Kjeldsen SE Edelman JM Dahlöf B Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study J Hypertens 2009 27 2271 2277en_US
dc.identifier.citedreferenceDahlöf B Devereux R de Faire U Fyhrquist F Hedner T Ibsen H Julius S Kjeldsen S Kristiansson K Lederballe‐Pedersen O Lindholm LH Nieminen MS Omvik P Oparil S Wedel H for the LIFE study group The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods Am J Hypertens 1997 10 705 713en_US
dc.identifier.citedreferenceOkin PM Roman MJ Devereux RB Kligfield P Electrocardiographic identification of increased left ventricular mass by simple voltage‐duration products J Am Coll Cardiol 1995 25 417 423en_US
dc.identifier.citedreferenceKannel WB D'Agostino RB Silbershatz H Belanger AJ Wilson PWF Levy D Profile for estimating risk of heart failure Arch Intern Med 1999 159 1197 1204en_US
dc.identifier.citedreferencePalmieri V Okin PM Bella JN Wachtell K Oikarinen L Gerdts E Boman K Nieminen MS Dahlöf B Devereux RB Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE Study J Hypertension 2006 24 2079 2084en_US
dc.identifier.citedreferenceRusso C Jin Z Homma S Rundek T Elkind MSV Sacco RL Di Tullio MR Effect of diabetes and hypertension on left ventricular diastolic function in a high‐risk population without evidence of heart disease Eur J Heart Fail 2010 12 454 461en_US
dc.identifier.citedreferenceRembert JC Kleinman LH Fedor JM Wechsler AS Greenfield JC Jr Myocardial blood flow distribution in concentric left ventricular hypertrophy J Clin Invest 1978 62 379 386en_US
dc.identifier.citedreferenceO'Keefe JH Owen RM Bove AA Influence of left ventricular mass on coronary artery cross‐sectional area Am J Cardiol 1987 59 1395 1397en_US
dc.identifier.citedreferenceAnderson HV Stokes MJ Leon M Abu‐Halawa SA Stuart Y Kirkeeide RL Coronary flow velocity in related to lumen area and regional left ventricular mass Circulation 2000 102 48 54en_US
dc.identifier.citedreferenceOkin PM Roman MJ Lee ET Galloway JM Howard BV Devereux RB Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study Hypertension 2004 43 769 774en_US
dc.identifier.citedreferenceDahlstrom U Hakansson J Swedberg K Waldenstrom A Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden Eur J Heart Fail 2009 11 92 98en_US
dc.identifier.citedreferenceSokolow M Lyon TP The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 1949 37 161 186en_US
dc.identifier.citedreferenceRomhilt DW Estes EH A point‐score system for the ECG diagnosis of left ventricular hypertrophy Am Heart J 1968 75 752 759en_US
dc.identifier.citedreferenceLevy D Labib SB Andersen KM Christiansen JC Kannel WB Castelli WP Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy Circulation 1990 81 815 820en_US
dc.identifier.citedreferenceSchillaci G Verdecchia P Borgioni C Ciucci A Guerrieri M Zampi I Battistelli M Bartoccini C Porecellata C Improved electrocardiographic diagnosis of echocardiographic left ventricular hypertrophy Am J Cardiol 1994 74 714 719en_US
dc.identifier.citedreferenceOkin PM Devereux RB Nieminen MS Jern S Oikarinen L Viitasalo M Toivonen L Kjeldsen SE Julius S Dahlöf B Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: The LIFE Study J Am Coll Cardiol 2001 38 514 520en_US
dc.identifier.citedreferenceOkin PM Devereux RB Fabsitz RR Lee ET Galloway JM Howard BV Quantitative assessment of electrocardiographic left ventricular strain predicts increased left ventricular mass: The Strong Heart Study J Am Coll Cardiol 2002 40 1395 1400en_US
dc.identifier.citedreferenceSalles G Cardoso C Nogueira AR Bloch K Muxfeldt E Importance of the electrocardiographic strain pattern in patients with resistant hypertension Hypertension 2006 48 437 442en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhfhfq224.pdf
Size:
183.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.